08:56 AM EDT, 07/17/2024 (MT Newswires) -- Health care stocks were flat to lower premarket Wednesday with the Health Care Select Sector SPDR Fund (XLV) unchanged and the iShares Biotechnology ETF (IBB) down 0.8% recently.

4D Molecular Therapeutics ( FDMT ) rose past 8% after saying interim data from a phase 2 study showed its experimental therapy, 4D-150, was safe and effective in treating patients with wet age-related macular degeneration.